Pages that link to "Q34043628"
Jump to navigation
Jump to search
The following pages link to In vivo genome editing using Staphylococcus aureus Cas9 (Q34043628):
Displaying 50 items.
- Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system (Q24669821) (← links)
- Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks (Q26741086) (← links)
- A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells (Q26741371) (← links)
- Recent Advances in Genome Editing Using CRISPR/Cas9 (Q26744073) (← links)
- CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases (Q26744172) (← links)
- Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing (Q26745465) (← links)
- An Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant-Pathogen Interactions for Better Crop Protection (Q26745534) (← links)
- The emerging role of viral vectors as vehicles for DMD gene editing (Q26746647) (← links)
- Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new (Q26748885) (← links)
- In Vivo Delivery Systems for Therapeutic Genome Editing (Q26748886) (← links)
- Customizing the genome as therapy for the β-hemoglobinopathies (Q26751061) (← links)
- Genome Engineering with TALE and CRISPR Systems in Neuroscience (Q26752488) (← links)
- Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future (Q26753206) (← links)
- Neurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomics (Q26764827) (← links)
- The Rise of CRISPR/Cas for Genome Editing in Stem Cells (Q26765852) (← links)
- Gene targeting, genome editing: from Dolly to editors (Q26768799) (← links)
- Genome-editing Technologies for Gene and Cell Therapy (Q26769662) (← links)
- CRISPR/Cas9 and cancer targets: future possibilities and present challenges (Q26769907) (← links)
- Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing (Q26770012) (← links)
- Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain (Q26770355) (← links)
- Genome Editing and Its Applications in Model Organisms (Q26772108) (← links)
- Revolutionizing plant biology: multiple ways of genome engineering by CRISPR/Cas (Q26773013) (← links)
- Towards a new era in medicine: therapeutic genome editing (Q26773287) (← links)
- Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation (Q26775746) (← links)
- Resources for the design of CRISPR gene editing experiments (Q26776435) (← links)
- Applications of CRISPR-Cas systems in neuroscience (Q26776515) (← links)
- Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system (Q26777421) (← links)
- How specific is CRISPR/Cas9 really? (Q26777801) (← links)
- Origins of Programmable Nucleases for Genome Engineering (Q26778501) (← links)
- Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases (Q26778992) (← links)
- Application of CRISPR/Cas9 Technology to HBV (Q26779150) (← links)
- A new age in functional genomics using CRISPR/Cas9 in arrayed library screening (Q26781135) (← links)
- Single-Base Pair Genome Editing in Human Cells by Using Site-Specific Endonucleases (Q26781370) (← links)
- Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research (Q26781399) (← links)
- Advances in therapeutic CRISPR/Cas9 genome editing (Q26782706) (← links)
- Enabling functional genomics with genome engineering (Q26782747) (← links)
- CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling (Q26782773) (← links)
- Strategies for precision modulation of gene expression by epigenome editing: an overview (Q26782876) (← links)
- Engineered Viruses as Genome Editing Devices (Q26785927) (← links)
- Designed nucleases for targeted genome editing (Q26787105) (← links)
- Use of designer nucleases for targeted gene and genome editing in plants (Q26799592) (← links)
- The CRISPR revolution and its impact on cancer research (Q26824997) (← links)
- Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9 (Q27011906) (← links)
- Genome-editing technologies for gene correction of hemophilia (Q28066273) (← links)
- Using CRISPR/Cas to study gene function and model disease in vivo (Q28072587) (← links)
- CRISPR-Mediated Epigenome Editing (Q28075872) (← links)
- Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity (Q28075883) (← links)
- CRISPR guide RNA design for research applications (Q28075898) (← links)
- The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges (Q28077484) (← links)
- Rapid Evolution of Manifold CRISPR Systems for Plant Genome Editing (Q28079621) (← links)